In particular, we detected CARD9 expression in the lymphoma cells from 53% of the RS cases, whereas de novo DLBCL and DLBCL arising through transformation of lymphomas other than CLL only rarely exhibited CARD9. Here, CARD9 is linked to diffuse large B-cell lymphoma.